Frank D. Lee

Frank D. Lee is a declared insider at 3 companies (chief executive); the most frequent names are Pacira BioSciences, Inc., Forma Therapeutics Holdings, Inc. and Bausch Health Companies Inc. We count 16 filings; the first trade dates from 26 February 2021 and the latest from 22 May 2026.

Both buying and selling appear: 1 purchase worth €91k, against 2 sales worth €260k. On balance, insiders were net sellers of €169k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 12 share grants.

The record was last updated on 26 May 2026 with a share grant in Bausch Health Companies Inc. The most recent open-market purchase was published on 13 August 2024, 802 days ago. Filings reach the SEC (Form 4) feed a median of 4 days after the trade. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.